Concert Pharma (CNCE) Tops Q3 EPS by 12c

November 8, 2016 7:22 AM EST
Get Alerts CNCE Hot Sheet
Trade CNCE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Concert Pharma (NASDAQ: CNCE) reported Q3 EPS of ($0.51), $0.12 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $26 thousand versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment